Labcorp and omniseq launch insight℠, next-generation sequencing platform to advance precision oncology

Buffalo, n.y., june 14, 2021 /prnewswire/ -- labcorp (nyse: lh), a leading global life sciences company, and omniseq, a cap-accredited, molecular diagnostic innovation of roswell park comprehensive cancer center, today announced the launch of omniseq insight℠, a comprehensive genomic and immune profiling, tissue-based test that integrates next-generation sequencing (ngs) technology.
LH Ratings Summary
LH Quant Ranking